Meyer Colin John - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 26, 2023, Meyer Colin John's relationship to REATA PHARMACEUTICALS INC (RETA) is Officer (Chief Innovation Officer), and currently has 0 shares of Class A common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RETA insiders.

Data Source: SEC.
Meyer Colin John - Insider Non-Derivative Transactions of RETA Class A common stock
Meyer Colin John - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 27, 2023 Disposition -- (Class A common stock) 81633 0 0
Aug 17, 2023 Sell -- (Class A common stock) 596 168.74 81633
Aug 16, 2023 Sell -- (Class A common stock) 2144 169.07 82229
Jul 7, 2023 Acquisition -- (Class A common stock) 6000 0 84373
May 17, 2023 Sell -- (Class A common stock) 625 80.94 78373
May 16, 2023 Sell -- (Class A common stock) 1139 85.77 78998
May 16, 2023 Sell -- (Class A common stock) 4469 84.76 80137
Mar 8, 2023 Sell -- (Class A common stock) 621 84.57 84606
Mar 4, 2023 Sell -- (Class A common stock) 5286 87.35 85227
Mar 3, 2023 Sell -- (Class A common stock) 810 90.58 90513
Mar 3, 2023 Sell -- (Class A common stock) 11181 88.5 91323
Mar 3, 2023 Sell -- (Class A common stock) 19099 87.55 102504
Mar 3, 2023 Sell -- (Class A common stock) 34794 86.49 121603
Mar 3, 2023 Sell -- (Class A common stock) 22752 85.23 156397
Mar 3, 2023 C -- (Class A common stock) 88636 0 179149
Mar 1, 2023 Acquisition -- (Class A common stock) 15000 0 90513
Jan 4, 2023 Acquisition -- (Class A common stock) 23513 0 75513